Florida Cerebrovascular Disease Biorepository and Genomics Center
Public ClinicalTrials.gov record NCT05491980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Creating a Florida Cerebrovascular Disease Biorepository and Genomics Center
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.
Study identification
- NCT ID
- NCT05491980
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 72 participants
Conditions and interventions
Conditions
- Cerebrovascular Disease
- Ischemic Stroke
- Transient Ischemic Attack
- Intracerebral Hemorrhage
- Aneurysmal Subarachnoid Hemorrhage
- Vascular Dementia
- Anoxic Brain Injury
- Unruptured Intracranial Aneurysm
- Carotid Artery Stenosis Symptomatic
- Asymptomatic Carotid Artery Stenosis
- Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage
- Cerebral Venous Thrombosis
- Moyamoya Disease
- Fibromuscular Dysplasia
- Subarachnoid Hemorrhage
- Leukoaraiosis
- Arteriovenous Fistula
- Reversible Cerebral Vasoconstriction Syndrome
- CADASIL
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2022
- Primary completion
- May 31, 2030
- Completion
- May 31, 2030
- Last update posted
- Sep 2, 2026
2022 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05491980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05491980 live on ClinicalTrials.gov.